# GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

> **NCT07513194** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 21 (estimated)

## Conditions studied

- Atypical Teratoid Rhabdoid Tumor
- Central Nervous System Rhabdoid Tumor

## Interventions

- **BIOLOGICAL:** 21.15.GPC3-CAR T Cells

## Key facts

- **NCT ID:** NCT07513194
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-10-31
- **Final completion:** 2044-10-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07513194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07513194, "GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07513194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*